AAPL301.45-31.98 (-9.59%) ▼|ABBV253.26-4.15 (-1.61%) ▼|ABT105.32-0.29 (-0.27%) ▼|ACN164.16+0.87 (+0.53%) ▲|ADBE247.51-0.39 (-0.16%) ▼|AMAT517.42+15.65 (+3.12%) ▲|AMD491.85+6.46 (+1.33%) ▲|AMGN383.06-4.59 (-1.18%) ▼|AMT171.56-2.90 (-1.66%) ▼|AMZN271.12+35.62 (+15.13%) ▲|AVGO388.40+0.56 (+0.14%) ▲|AXP337.05-0.48 (-0.14%) ▼|BA215.29-5.61 (-2.54%) ▼|BAC62.13+0.40 (+0.64%) ▲|BKNG193.56+0.32 (+0.17%) ▲|BLK1,094.06-4.31 (-0.39%) ▼|BMY64.82-0.04 (-0.06%) ▼|BNY156.90+0.82 (+0.53%) ▲|BRK-B511.21+1.53 (+0.30%) ▲|C132.92+0.60 (+0.45%) ▲|CAT817.71+8.57 (+1.06%) ▲|CL91.20-0.40 (-0.44%) ▼|CMCSA23.94+0.27 (+1.14%) ▲|COF207.67-2.47 (-1.18%) ▼|COP118.82-0.21 (-0.18%) ▼|COST950.23-3.95 (-0.41%) ▼|CRM182.56+1.85 (+1.02%) ▲|CSCO115.55+1.99 (+1.75%) ▲|CVS105.39+0.17 (+0.16%) ▲|CVX195.19+2.88 (+1.50%) ▲|DE595.47-4.01 (-0.67%) ▼|DHR195.61-0.57 (-0.29%) ▼|DIS95.99-0.18 (-0.18%) ▼|DUK125.79-0.48 (-0.38%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX309.14+0.59 (+0.19%) ▲|GD383.02+0.82 (+0.21%) ▲|GE361.00+5.96 (+1.68%) ▲|GEV996.01+14.03 (+1.43%) ▲|GILD129.87-1.41 (-1.07%) ▼|GM88.11-0.29 (-0.33%) ▼|GOOG354.24+20.56 (+6.16%) ▲|GOOGL354.36+20.70 (+6.20%) ▲|GS1,022.19-2.67 (-0.26%) ▼|HD331.56-1.79 (-0.54%) ▼|HON243.16+1.25 (+0.52%) ▲|IBM220.53-1.21 (-0.55%) ▼|INTC92.55+1.42 (+1.56%) ▲|INTU314.77-0.73 (-0.23%) ▼|ISRG352.49-0.49 (-0.14%) ▼|JNJ257.69+1.87 (+0.73%) ▲|JPM353.62+2.77 (+0.79%) ▲|KO87.38-1.11 (-1.25%) ▼|LIN479.24-29.41 (-5.78%) ▼|LLY1,143.06-11.91 (-1.03%) ▼|LMT579.10+4.99 (+0.87%) ▲|LOW208.93-1.16 (-0.55%) ▼|LRCX303.00+5.28 (+1.77%) ▲|MA571.41-5.95 (-1.03%) ▼|MCD269.10+0.66 (+0.25%) ▲|MDLZ62.10-0.98 (-1.55%) ▼|MDT84.99-0.72 (-0.84%) ▼|META549.32+10.29 (+1.91%) ▲|MMM175.94-0.13 (-0.07%) ▼|MO69.08+1.14 (+1.68%) ▲|MRK130.77+0.98 (+0.76%) ▲|MS211.12+2.21 (+1.06%) ▲|MSFT463.52+12.42 (+2.75%) ▲|MU837.36-37.30 (-4.26%) ▼|NEE87.90-0.03 (-0.03%) ▼|NFLX71.56-1.61 (-2.20%) ▼|NKE41.70-0.59 (-1.40%) ▼|NOW110.88+0.81 (+0.74%) ▲|NVDA198.18+3.14 (+1.61%) ▲|ORCL128.47+0.91 (+0.71%) ▲|PEP139.39-0.81 (-0.58%) ▼|PFE25.10+0.19 (+0.76%) ▲|PG143.74-0.23 (-0.16%) ▼|PLTR122.40+0.14 (+0.11%) ▲|PM192.45+0.45 (+0.23%) ▲|QCOM148.65-2.95 (-1.95%) ▼|RTX215.15+0.77 (+0.36%) ▲|SBUX104.88-0.97 (-0.92%) ▼|SCHW105.35+1.02 (+0.97%) ▲|SO94.76+0.42 (+0.44%) ▲|SPG231.27+0.83 (+0.36%) ▲|T23.20-0.02 (-0.06%) ▼|TMO571.28-5.49 (-0.95%) ▼|TMUS171.75-1.59 (-0.92%) ▼|TSLA309.36+0.51 (+0.17%) ▲|TXN276.89-1.88 (-0.67%) ▼|UBER69.89-0.48 (-0.68%) ▼|UNH420.57-0.90 (-0.21%) ▼|UNP292.43+2.97 (+1.03%) ▲|UPS104.42-0.85 (-0.81%) ▼|USB63.18+0.28 (+0.45%) ▲|V364.80-1.47 (-0.40%) ▼|VZ46.48+0.37 (+0.80%) ▲|WFC86.58+1.15 (+1.34%) ▲|WMT111.39+0.29 (+0.26%) ▲|XOM153.89-3.09 (-1.97%) ▼|AAPL301.45-31.98 (-9.59%) ▼|ABBV253.26-4.15 (-1.61%) ▼|ABT105.32-0.29 (-0.27%) ▼|ACN164.16+0.87 (+0.53%) ▲|ADBE247.51-0.39 (-0.16%) ▼|AMAT517.42+15.65 (+3.12%) ▲|AMD491.85+6.46 (+1.33%) ▲|AMGN383.06-4.59 (-1.18%) ▼|AMT171.56-2.90 (-1.66%) ▼|AMZN271.12+35.62 (+15.13%) ▲|AVGO388.40+0.56 (+0.14%) ▲|AXP337.05-0.48 (-0.14%) ▼|BA215.29-5.61 (-2.54%) ▼|BAC62.13+0.40 (+0.64%) ▲|BKNG193.56+0.32 (+0.17%) ▲|BLK1,094.06-4.31 (-0.39%) ▼|BMY64.82-0.04 (-0.06%) ▼|BNY156.90+0.82 (+0.53%) ▲|BRK-B511.21+1.53 (+0.30%) ▲|C132.92+0.60 (+0.45%) ▲|CAT817.71+8.57 (+1.06%) ▲|CL91.20-0.40 (-0.44%) ▼|CMCSA23.94+0.27 (+1.14%) ▲|COF207.67-2.47 (-1.18%) ▼|COP118.82-0.21 (-0.18%) ▼|COST950.23-3.95 (-0.41%) ▼|CRM182.56+1.85 (+1.02%) ▲|CSCO115.55+1.99 (+1.75%) ▲|CVS105.39+0.17 (+0.16%) ▲|CVX195.19+2.88 (+1.50%) ▲|DE595.47-4.01 (-0.67%) ▼|DHR195.61-0.57 (-0.29%) ▼|DIS95.99-0.18 (-0.18%) ▼|DUK125.79-0.48 (-0.38%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX309.14+0.59 (+0.19%) ▲|GD383.02+0.82 (+0.21%) ▲|GE361.00+5.96 (+1.68%) ▲|GEV996.01+14.03 (+1.43%) ▲|GILD129.87-1.41 (-1.07%) ▼|GM88.11-0.29 (-0.33%) ▼|GOOG354.24+20.56 (+6.16%) ▲|GOOGL354.36+20.70 (+6.20%) ▲|GS1,022.19-2.67 (-0.26%) ▼|HD331.56-1.79 (-0.54%) ▼|HON243.16+1.25 (+0.52%) ▲|IBM220.53-1.21 (-0.55%) ▼|INTC92.55+1.42 (+1.56%) ▲|INTU314.77-0.73 (-0.23%) ▼|ISRG352.49-0.49 (-0.14%) ▼|JNJ257.69+1.87 (+0.73%) ▲|JPM353.62+2.77 (+0.79%) ▲|KO87.38-1.11 (-1.25%) ▼|LIN479.24-29.41 (-5.78%) ▼|LLY1,143.06-11.91 (-1.03%) ▼|LMT579.10+4.99 (+0.87%) ▲|LOW208.93-1.16 (-0.55%) ▼|LRCX303.00+5.28 (+1.77%) ▲|MA571.41-5.95 (-1.03%) ▼|MCD269.10+0.66 (+0.25%) ▲|MDLZ62.10-0.98 (-1.55%) ▼|MDT84.99-0.72 (-0.84%) ▼|META549.32+10.29 (+1.91%) ▲|MMM175.94-0.13 (-0.07%) ▼|MO69.08+1.14 (+1.68%) ▲|MRK130.77+0.98 (+0.76%) ▲|MS211.12+2.21 (+1.06%) ▲|MSFT463.52+12.42 (+2.75%) ▲|MU837.36-37.30 (-4.26%) ▼|NEE87.90-0.03 (-0.03%) ▼|NFLX71.56-1.61 (-2.20%) ▼|NKE41.70-0.59 (-1.40%) ▼|NOW110.88+0.81 (+0.74%) ▲|NVDA198.18+3.14 (+1.61%) ▲|ORCL128.47+0.91 (+0.71%) ▲|PEP139.39-0.81 (-0.58%) ▼|PFE25.10+0.19 (+0.76%) ▲|PG143.74-0.23 (-0.16%) ▼|PLTR122.40+0.14 (+0.11%) ▲|PM192.45+0.45 (+0.23%) ▲|QCOM148.65-2.95 (-1.95%) ▼|RTX215.15+0.77 (+0.36%) ▲|SBUX104.88-0.97 (-0.92%) ▼|SCHW105.35+1.02 (+0.97%) ▲|SO94.76+0.42 (+0.44%) ▲|SPG231.27+0.83 (+0.36%) ▲|T23.20-0.02 (-0.06%) ▼|TMO571.28-5.49 (-0.95%) ▼|TMUS171.75-1.59 (-0.92%) ▼|TSLA309.36+0.51 (+0.17%) ▲|TXN276.89-1.88 (-0.67%) ▼|UBER69.89-0.48 (-0.68%) ▼|UNH420.57-0.90 (-0.21%) ▼|UNP292.43+2.97 (+1.03%) ▲|UPS104.42-0.85 (-0.81%) ▼|USB63.18+0.28 (+0.45%) ▲|V364.80-1.47 (-0.40%) ▼|VZ46.48+0.37 (+0.80%) ▲|WFC86.58+1.15 (+1.34%) ▲|WMT111.39+0.29 (+0.26%) ▲|XOM153.89-3.09 (-1.97%) ▼|
29.8 C
New York
Friday, July 31, 2026

Tag: oral

COLGATE DENTAL VEER ANTHEM LAUNCHED TO EMPOWER KIDS TO BE THEIR OWN HEROES OF ORAL HEALTH

Released close to Independence Day, the anthem is penned by lyricist Swanand Kirkire and composed by Micu Patel Link to the anthem - Colgate Dental...

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Greywolf starts first trial of GRWD0715, aiming for a functional cure for autoimmunity by targeting its antigenic source.

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

-         The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in...

Artemis Gold Reports Q2 2025 Results Consistent with Guidance: Q2 Production of 50,623 ounces gold and Post-commercial AISC US$805 per ounce, and Announces $700M...

TSXV: ARTG (all amounts in Canadian dollars unless otherwise stated) VANCOUVER, BC, Aug. 12, 2025 /CNW/ - Artemis Gold Inc. (TSXV: ARTG) ("Artemis Gold" or the...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

•   First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026

Terrestrial Energy Selected for DOE Office of Nuclear Energy Advanced Reactor Pilot Program for Accelerated Development

Advanced Reactor Pilot Program launched by DOE to expedite authorization and commercialization of advanced nuclear reactor designs

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

— Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI 10...

First Mining Announces 2025 Second Quarter Financial Results and Operating Highlights

VANCOUVER, BC, Aug. 12, 2025 /CNW/ - First Mining Gold Corp. ("First Mining" or the "Company") (TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) reports its second...

First Mining Announces 2025 Second Quarter Financial Results and Operating Highlights

VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ - First Mining Gold Corp. ("First Mining" or the "Company") (TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) reports its second...

Sleep Health Week: Researchers Recruiting Now for CBD Insomnia Trial

During Sleep Health Week (11-15 August 2025), Australians living with insomnia are reminded that a new treatment is on the horizon – with clinical...

IBAT Inhibitors Market Witnesses Strong Growth During the Forecast Period (2025-2034) Owing to the Rising Demand for Rare Cholestatic Liver Disease Therapies | DelveInsight

The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a...

IBAT Inhibitors Market Witnesses Strong Growth During the Forecast Period (2025-2034) Owing to the Rising Demand for Rare Cholestatic Liver Disease Therapies | DelveInsight

The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOral